Clinical Trial Update: Prospective Trial to Evaluate the Safety and Efficacy to Treat Esophageal Cancer Using 5-FU, Oxaliplatin, and Docetaxel [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is underway to evaluate the safety and efficacy of a chemotherapy regimen (5-FU, oxaliplatin, and docetaxel) for esophageal squamous ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• 5-FU (5-fluorouracil) (5-fluorouracil)
• DOCETAXEL (DOCETAXEL)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Keio University | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN